Dr Thomas Seyfried: The Truth About Cancer

Joining us live from the United States on July 10, 2023, Dr Thomas Seyfried spoke with WCH team member Linda Mathews-Rae at General Assembly Meeting #95 about his groundbreaking views on cancer being a metabolic disease rather than a genetic one.

Who is Dr Thomas Seyfried?

  • Dr Thomas Seyfried is a professor of biology, genetics, and biochemistry at Boston College.
  • This view dramatically impacts the approach to cancer management and prevention as Dr Seyfried suggests the use of metabolic therapies which include calorific restriction, fasting and ketogenic diets.
  • He has been published in over 150 peer-reviewed publications.
  • The FLCCC’s Dr Paul Marik cites Dr Seyfried’s work extensively. Learn more about it at tomseyfried.com.

Find this important video to share on Rumble, Facebook, Odysee, and Bitchute.

This is an edited segment from the weekly live General Assembly Meeting on July 10, 2023. Dr Paul Marik also spoke at this meeting.

Leave a Reply

Your email address will not be published. Required fields are marked *

4 Comments

  1. Thanks for discussion, good to hear how treatments could progress moving forward, as I don’t like the unquestioning complicity of many nhs staff during covid. I know some spoke out & were silence, some indoctrinated and some just evil genocidal maniacs.

    Reply

  2. This is phenomenal news. I didn’t know that the majority of cancers run on fermentation. I’ll be sure to forward this to my parents and loved ones who have cancer. I’ve read about the gaming of randomized controlled trials by pharmaceutical companies and hadn’t thought about the supplanting of them by longitudinal cohort studies as a way to study the effectiveness of drugs and treatments. I thought cancer was purely by random mutation in the genetic code, hastened by the elevated carcinogens in the environment. It’s nice to hear somebody on the cutting edge of understanding the metabolic biochemical interactions as it relates to cancer. I think a note of caution is to begin this treatment on cancer patients that the current treatments are not very effective at treating. If you can prove your hypothesis by effectively treating those with high mortality and morbidity at current rates then you can move down the chain of cancers with better treatments.

    Reply

  4. It’s good to hear a different bit of advice. My mother & father in law may have cancer. They are waiting for results.

    Is there any other advice can you give please?

    Reply